Cargando…
Efficacy and Safety of Add-On Plant-Based Drugs for COVID-19 Patients: A Review of the Randomized Control Trials
COVID‐19 caused by the infection of SARS‐CoV‐2 is still a global concern. WHO reported that from 13 March to 9 April 2023, there were 3 million new cases and approximately 23,000 deaths, mostly occurring in the South-East Asia and Eastern Mediterranean regions, which is predicted due to the new Omic...
Autores principales: | Diantini, Ajeng, Febriyanti, R Maya, Levita, Jutti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289101/ https://www.ncbi.nlm.nih.gov/pubmed/37361940 http://dx.doi.org/10.2147/IDR.S417727 |
Ejemplares similares
-
Efficacy, Safety, and Drug–Drug Interactions for Insomnia Therapy in COVID-19 Patients
por: Saputra, Billy Dwi, et al.
Publicado: (2022) -
Pharmacokinetics of 10-gingerol and 6-shogaol in the plasma of healthy subjects treated with red ginger (Zingiber officinale var. Rubrum) suspension
por: Levita, Jutti, et al.
Publicado: (2018) -
Effect of the roselle (Hibiscus sabdariffa L.) calyces drink on the physiological parameters of healthy adult subjects
por: Diantini, Ajeng, et al.
Publicado: (2021) -
Clinical Toxicology of Vitamin D in Pediatrics: A Review and Case Reports
por: Levita, Jutti, et al.
Publicado: (2023) -
Pharmacology activity, toxicity, and clinical trials of Erythrina genus plants (Fabaceae): an evidence-based review
por: Susilawati, Elis, et al.
Publicado: (2023)